Equity (Details) - USD ($)				1 Months Ended	3 Months Ended
	Oct. 02, 2020	Apr. 21, 2020	Jun. 06, 2018	Aug. 31, 2020	Nov. 30, 2020
Equity (Details) [Line Items]
Common stock, shares authorized				800,000,000
Common stock, par value				$ 0.001	$ 0.001
Preferred stock, shares authorized				50,000,000	50,000,000
Preferred stock, par value				$ 0.001	$ 0.001
Description of stock	On October 2, 2020, the Company filed a certificate of amendment to the Company’s articles of incorporation with the Secretary of State of Nevada, pursuant to which the Company increased its authorized shares of common stock from 800,000,000 to 3,000,000,000. 1,000 shares of preferred stock are designated as Series A Convertible Preferred Stock.
Debt instrument, annual principal amount				$ 150,000
Common stock aggregate shares					20,000,000
Common stock aggregate amount					$ 200,000
Investor [Member] | Securities Purchase Agreement [Member]
Equity (Details) [Line Items]
Description of common stock			on June 6, 2018 the Company was obligated to issue additional shares of common stock if the Company sold common stock at a price lower than $0.10 per share (or common stock equivalents with an exercise price less than $0.10 per share) during the six month period following the closing of the purchase agreement, in which event the Company was required to issue additional shares to the purchaser for no additional consideration, such that the total number of common stock received by the purchaser will be equal to $50,000 divided by lower financing price. As of August 31, 2020, the Company was obligated to issue 500,000 shares of common stock valued at $76,000. On January 5, 2021, the Company issued the 500,000 shares of common stock (see Note 9).
Series C Preferred Stock [Member]
Equity (Details) [Line Items]
Preferred stock, par value				$ 0.001	$ 0.001
Preferred stock, designated shares				1	1
Holder voting power, description					The Series C Preferred Stock has a stated value of $24,000 and entitles the holder to 51% of the total voting power of the Company’s stockholders.
Series B Preferred Stock [Member]
Equity (Details) [Line Items]
Letter agreement, description				Upon execution of the note, $120,000 was remitted and the remaining $30,000 was remitted on September 22, 2020. The note did not bear interest. On November 10, 2020, the Company entered into an exchange agreement with Mr. Pollack. Pursuant to the exchange agreement, Mr. Pollack exchanged the promissory note issued August 31, 2020 for 15,000,000 newly issued shares of common stock of the Company.
Options [Member] | Danil Pollack [Member]
Equity (Details) [Line Items]
Employment agreement, description		Pursuant to the employment agreement, Mr. Pollack will serve as the Company’s chief executive officer and president for a period of one year, which term will renew automatically for successive one year terms, subject to the right of either party to terminate the agreement at any time upon written notice. Mr. Pollack was granted the right, for a period of six months, to purchase up to 100,000,000 shares of common stock of the Company for a purchase price of $0.001 per share. The Company recognized option expense of $1,416,975 during the year ended August 31, 2020. During the year ended August 31, 2020, Mr. Pollack exercised 84,000,000 stock options for $84,000. During the three months ended November 30, 2020, the remaining 16,000,000 stock options expired.